FOXP3 and melanoma: Unlike treatment of radiosensitive MC38 tumors (Tadepalli et al., 2023), RT led to an increase in the numbers of FOXP3+ Tregs, resulting in a decreased TIL/Treg ratio in both B16 and BRaf/Pten melanoma tumors (Fig. 1 D and Fig. S1 B).